Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.000
+0.006 (0.59%)
Nov 21, 2024, 2:46 PM EST - Market open
Rallybio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 25.32 | 24.49 | 56.96 | 175.33 | 140.23 | 19.46 |
Short-Term Investments | 49.82 | 85.44 | 112.04 | - | - | - |
Cash & Short-Term Investments | 75.14 | 109.93 | 168.99 | 175.33 | 140.23 | 19.46 |
Cash Growth | -38.10% | -34.95% | -3.62% | 25.03% | 620.70% | - |
Prepaid Expenses | 0.89 | 0.74 | 1.55 | 1.84 | 1.03 | 1.46 |
Other Current Assets | 2.2 | 4.12 | 8.95 | 3.7 | - | - |
Total Current Assets | 78.23 | 114.79 | 179.5 | 180.87 | 141.26 | 20.92 |
Property, Plant & Equipment | 0.35 | 0.59 | 0.91 | 0.51 | 0.29 | 0.2 |
Long-Term Investments | 0.43 | 0.24 | 0.03 | 0.81 | 0.31 | 0.49 |
Total Assets | 79.01 | 115.62 | 180.44 | 182.19 | 141.86 | 21.61 |
Accounts Payable | 0.58 | 0.98 | 1.11 | 0.6 | 1.58 | 0.86 |
Accrued Expenses | 6.28 | 8.07 | 9.45 | 5.95 | 3.27 | 1.36 |
Current Portion of Leases | 0.23 | 0.22 | 0.18 | - | - | - |
Other Current Liabilities | - | - | - | - | 0.99 | 1.59 |
Total Current Liabilities | 8.19 | 9.26 | 10.74 | 6.55 | 5.84 | 3.81 |
Long-Term Leases | - | 0.17 | 0.37 | - | - | - |
Other Long-Term Liabilities | - | - | - | 0.03 | 0.01 | 0.94 |
Total Liabilities | 8.19 | 9.44 | 11.12 | 6.58 | 5.86 | 4.75 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.23 |
Additional Paid-In Capital | 352.62 | 341.41 | 330.21 | 269.63 | 183.02 | - |
Retained Earnings | -281.98 | -235.25 | -160.68 | -94.03 | -47.01 | -20.57 |
Comprehensive Income & Other | 0.17 | 0.02 | -0.21 | - | - | 0.06 |
Total Common Equity | 70.82 | 106.18 | 169.32 | 175.6 | 136 | -20.28 |
Shareholders' Equity | 70.82 | 106.18 | 169.32 | 175.6 | 136 | 16.86 |
Total Liabilities & Equity | 79.01 | 115.62 | 180.44 | 182.19 | 141.86 | 21.61 |
Total Debt | 0.23 | 0.39 | 0.56 | - | - | - |
Net Cash (Debt) | 74.91 | 109.54 | 168.44 | 175.33 | 140.23 | 19.46 |
Net Cash Growth | -38.07% | -34.97% | -3.93% | 25.03% | 620.70% | - |
Net Cash Per Share | 1.76 | 2.71 | 5.29 | 6.87 | 8.06 | 11.34 |
Filing Date Shares Outstanding | 41.49 | 37.81 | 38.08 | 32.13 | 5.7 | 1.72 |
Total Common Shares Outstanding | 41.49 | 37.83 | 37.84 | 32.13 | 5.7 | 1.72 |
Working Capital | 70.04 | 105.53 | 168.75 | 174.32 | 135.42 | 17.11 |
Book Value Per Share | 1.71 | 2.81 | 4.47 | 5.47 | 23.86 | -11.82 |
Tangible Book Value | 70.82 | 106.18 | 169.32 | 175.6 | 136 | -20.28 |
Tangible Book Value Per Share | 1.71 | 2.81 | 4.47 | 5.47 | 23.86 | -11.82 |
Machinery | - | 0.34 | 0.33 | 0.31 | 0.11 | 0.1 |
Construction In Progress | - | - | - | 0.01 | - | - |
Leasehold Improvements | - | 0.34 | 0.34 | 0.32 | 0.18 | 0.08 |
Source: S&P Capital IQ. Standard template. Financial Sources.